Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
- Status
- COMPLETED
- Phase
- PHASE3
Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX
- Status
- COMPLETED
- Phase
- N/A
A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS)
- Status
- COMPLETED
- Phase
- N/A
4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children
- Status
- UNKNOWN
- Phase
- PHASE3
Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma
- Status
- COMPLETED
- Phase
- N/A
Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis
- Status
- COMPLETED
- Phase
- NA
Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
- Status
- COMPLETED
- Phase
- PHASE3
Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of an Etoricoxib and Tizanidine Fixed Dose Combination in Participants With Moderate to Severe Acute Low Back Pain (MK-0663B-164)
- Status
- WITHDRAWN
- Phase
- PHASE3
Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen
- Status
- COMPLETED
- Phase
- NA
Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Biomarkers of Anti-TNF Treatment in Inflammatory Bowel Disease (IBD)
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex
- Status
- COMPLETED
- Phase
- NA
Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)
- Status
- COMPLETED
- Phase
- PHASE1